Myocardial ultrasound tissue characterization in patients with chronic renal failure

Journal of the American Society of Nephrology

Volumn 18, Issue 6, 2007, Pages 1953-1958

  Salvetti, Massimo ^a   Muiesan, Maria Lorenza ^a   Paini, Anna ^a   Monteduro, Cristina ^a   Bonzi, Bianca ^a   Galbassini, Gloria ^a   Belotti, Eugenia ^a   Movilli, Ezio ^a   Cancarini, Giovanni ^a   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CREATININE;

ADULT; AGE; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENSITOMETRY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 34249863855     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006050462     Document Type: Article

References (33)

1. Vakili BA, Okin PM, Devereux RB: Prognostic implications of left ventricular hypertrophy. Am Heart J 141: 334-341, 2001
2. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E: Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 13: 1091-1095, 1995
3. Verdecchia P, Angeli F, Borgioni C, Gattobigio R, de Simone G, Devereux RB, Porcellati C: Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: A meta-analysis. Am J Hypertens 16: 895-899, 2003
4. Devereux RB, Dahlof B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K: Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110: 1456-1462, 2004
5. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2003
7. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
8. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290, 1989
9. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024-2031, 1995
10. Middleton RJ, Parfrey PS, Foley RN: Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12: 1079-1084, 2001
11. Mimbs JW, O'Donnell M, Bauwens D, Miller JW, Sobel BE: The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts. Circ Res 47: 49-58, 1980
12. Perez JE, Barzilai B, Madaras EI, Glueck RM, Saffitz JE, Johnston P, Miller JG, Sobel BE: Applicability of ultrasonic tissue characterization for longitudinal assessment and differentiation of calcification and fibrosis in cardiomyopathy. J Am Coll Cardiol 4: 88-95, 1984
13. O'Donnell M, Mimbs JW, Miller JG: Relationship between collagen and ultrasonic backscatter in myocardial tissue. J Acoust Soc Am 69: 580-588, 1981
14. Hoyt RM, Skorton DJ, Collins SM, Melton HE Jr: Ultrasonic backscatter and collagen in normal ventricular myocardium. Circulation 69: 775-782, 1984
15. Picano E, Pelosi G, Marzilli M, Lattanzi F, Benassi A, Landini L, L'Abbate A: In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 81: 58-64, 1990
16. Naito J, Masuyama T, Mano T, Kondo H, Yamamoto K, Nagano R, Doi Y, Hori M, Kamada T: Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: Value in noninvasive assessment of myocardial fibrosis. Am Heart J 131: 115-121, 1996
17. Fujimoto S, Mizuno R, Nakagawa Y, Kimura A, Yamaji K, Yutani C, Dohi K, Nakano H: Ultrasonic tissue characterization in patients with dilated cardiomyopathy: Comparison with findings from right ventricular endomyocardial biopsy. Int J Card Imaging 15: 391-396, 1999
18. Di Bello V, Giorgi D, Viacava P, Enrica T, Nardi C, Palagi C, Grazia Delle Donne M, Verunelli F, Mariani MA, Grandjean J, Dell'Anna R, Di Cori A, Zucchelli G, Romano MF, Mariani M: Severe aortic stenosis and myocardial function: Diagnostic and prognostic usefulness of ultrasonic integrated backscatter analysis. Circulation 110: 849-855, 2004
19. Di Bello V, Giorgi D, Talini E, Dell' Omo G, Palagi C, Romano MF, Pedrinelli R, Mariani M: Incremental value of ultrasonic tissue characterization (backscatter) in the evaluation of left ventricular myocardial structure and mechanics in essential arterial hypertension. Circulation 107: 74-80, 2003
20. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978
21. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19: 1550-1558, 1992
22. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618, 1977
23. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260, 1992
24. Muiesan ML, Salvetti M, Rizzoni D, Monteduro C, Castellano M, Agabiti-Rosei E: Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up. J Hypertens Suppl 14: S43-S49, 1996
25. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA: Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15: 167-184, 2002
26. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 19: 990-1003, 1998
27. Levin A, Singer J, Thompson C, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354, 1996
28. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, Leoncini G, Del Sette M, Brunelli C, Tomolillo C, Deferrari G: Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 17: 993-1000, 1999
29. Wickline SA, Thomas LJ 3rd, Miller JG, Sobel BE, Perez JE: A relationship between ultrasonic integrated backscatter and myocardial contractile function. J Clin Invest 76: 2151-2160, 1985
30. Maceira AM, Barba J, Varo N, Beloqui O, Diez J: Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives. Hypertension 39: 923-928, 2002
31. Mizushige K, Tokudome T, Seki M, Kondo I, Hirao K, Nozaki S, Miki S, Yuasa S, Matsuo H: Sensitive detection of myocardial contraction abnormality in chronic hemodialysis patients by ultrasonic tissue characterization with integrated backscatter. Angiology 51: 223-230, 2000
32. Akar H, Ceyhan C, Yenicerioglu Y, Keven K, Onbasili A, Tekten T: Cardiac cyclic variation of integrated backscatter in hypertension and dialysis patients. J Nephrol 17: 270-274, 2004
33. Koyama J, Ray-Sequin PA, Falk RH: Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation 106: 556-561, 2002